Dargen 40mcg Injection

Dargen 40mcg Injection About

Dargen 40 mcg Injection (PFS) contains darbepoetin alfa, an erythropoiesis-stimulating agent used to treat anemia caused by chronic kidney disease (CKD) in adults and children. It works by stimulating red blood cell production, helping improve hemoglobin levels and reduce symptoms such as fatigue and weakness. Regular blood tests and blood pressure monitoring are required to ensure safe and effective treatment.

Dargen is not recommended for patients with uncontrolled hypertension and should be used with caution in individuals with liver disease, seizures, sickle cell anemia, or a history of poor response to anemia therapy. Use during pregnancy should be carefully evaluated, breastfeeding is not advised, and treatment in infants or children should be undertaken only under strict medical supervision.